| Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer |
assessment of therapy complications, case management, educational intervention, management of therapy complications, physical therapy, quality-of-life assessment, questionnaire administration, telephone-based intervention |
Active, not recruiting |
| Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin |
Fat Emulsion, Placebo |
Active, not recruiting |
| Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer |
Chemotherapy, Disulfiram, Gemcitabine Hydrochloride, Laboratory Biomarker Analysis |
Active, not recruiting |
| Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue |
Digital Tomosynthesis Mammography, Scintimammography |
Active, not recruiting |
| FAST (Focused Abbreviated Screening Technique)-MRI Study |
|
Enrolling by invitation |
| Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy |
|
Enrolling by invitation |
| Learning Collaborative Vs Technical Assistance in Delivering a Palliative Care Program to Patients With Advanced Cancer |
Technical Assistance, Virtual Learning Collaborative |
Enrolling by invitation |
| Problem-Solving Therapy for Cancer Caregivers in Outpatient Palliative Care |
Attention-matched Control, In-depth interviews, Problem-Solving Therapy |
Enrolling by invitation |
| A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients |
Biospecimen Collection, Letermovir |
Not yet recruiting |
| Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial |
Laser Therapy, Quality of Life Assessment, Questionnaire Administration, Sham Intervention |
Not yet recruiting |
| Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer |
Biospecimen Collection, Tamoxifen, Random Periareolar Fine-Needle Aspiration, Acolbifene Hydrochloride, Mammography |
Not yet recruiting |
| Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors |
Placebo Administration, Delta-8-Tetrahydrocannabinol, Cannabidiol, Questionnaire Administration |
Not yet recruiting |
| Testing ONC201 to Prevent Colorectal Cancer |
Biospecimen Collection, Biopsy, Colonoscopy, Sigmoidoscopy, Questionnaire Administration, Dordaviprone |
Not yet recruiting |
| Study to Determine Possible Effects of Apalutamide on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer |
Apalutamide, Biospecimen Collection, Questionnaire Administration, Transurethral Resection of Bladder Tumor |
Not yet recruiting |
| Testing RG1-VLP Vaccine to Prevent HPV-related Cancers |
Biospecimen Collection, Questionnaire Administration, HPV16 RG1 VLP Vaccine, Recombinant Human Papillomavirus Nonavalent Vaccine, Saline |
Not yet recruiting |
| Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial |
Biopsy, Biospecimen Collection, Placebo Administration, Urolithin A Supplement |
Not yet recruiting |
| Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial |
Biopsy, Biospecimen Collection, Mammography, Questionnaire Administration, Tamoxifen |
Not yet recruiting |
| Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction |
Biospecimen Collection, Mammography, Omega-3-Acid Ethyl Esters, Questionnaire Administration, Random Periareolar Fine-Needle Aspiration, Tamoxifen |
Not yet recruiting |
| Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts |
Non-Interventional Study |
Not yet recruiting |
| A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy |
Aspirin, Omeprazole |
Not yet recruiting |